王子龙

助理教授 医学院, 医学神经科学系

王子龙,南方科技大学医学院助理教授,博士生导师。2011年毕业于兰州大学生物学人才培养基地,2017年获得兰州大学-杜克大学联合培养博士学位。随后在杜克大学进行博士后研究。王子龙长期致力于痛觉和痒觉的分子细胞和神经机制研究,以及镇痛或止痒药物的研发。以第一或通讯作者(含共同)在Science Translational Medicine、Brain、Neuron、Gastroenterology、J Med Chem.、Anesthesiology、Neuropharmacology等国际期刊上发表SCI 论文11篇,以合作作者在Nature、Neuron(3篇)、Journal of clinical investigation、Nature communications(2篇)等国际期刊上发表SCI 论文30篇,总共发表SCI论文41篇;被引大于1000次,H-index为18。以主要发明人申请国家发明专利7 件(已授权5件),美国专利2件,国际专利PCT 3件。

●教育背景

2007.09 – 2011.06,兰州大学,学士,生物科学

2011.09 – 2017.06,兰州大学,博士,生物化学与分子生物学

2016.01 – 2017.01,杜克大学,联合培养博士,神经学系

 

●工作经历

2017.01 – 2017.10,杜克大学医学院,访问学生,麻醉学系

2017.10 – 2021.01,杜克大学医学院,博士后,麻醉学系

2021.03 –至今, 南方科技大学医学院,助理教授、博士生导师

个人简介

王子龙,南方科技大学医学院助理教授,博士生导师。2011年毕业于兰州大学生物学人才培养基地,2017年获得兰州大学-杜克大学联合培养博士学位。随后在杜克大学进行博士后研究。王子龙长期致力于痛觉和痒觉的分子细胞和神经机制研究,以及镇痛或止痒药物的研发。已发表相关领域SCI论文33篇,其中以第一作者或通讯作者发表论文10篇,包括“Science Translational Medicine”、“Brain”、“Gastroenterology”、“Neuron”等高水平杂志。另外本人作为主要发明人申请中国国家发明专利7项,已获授权5项;申请国际专利PCT 3项,美国专利1项。

研究领域

实验室研究方向主要涉及“痛觉”、“痒觉”、和“新型镇痛或止痒药物研发”等。主要研究方向包括:

(1)痛觉及痒觉的神经机制及新靶点的发现;

(2)免疫-神经相互作用;

(3)病理性疼痛的细胞分子机制研究及其临床治疗新药新技术研发;

(4)阿片类药物镇痛及其副作用的细胞分子以及神经环路机制;

(5)镇痛或止痒药物研发。

教育背景

2007.09 – 2011.06,兰州大学学士,生物科学专业

2011.09 – 2017.06,兰州大学-杜克大学联合培养博士,生物化学与分子生物学专业

工作经历

2017.10 – 2021.01,杜克大学医学院,博士后研究员

2021.03 – 至今,南方科技大学医学院,助理教授、博士生导师

获奖情况及荣誉

2015年 国家奖学金

2017年 兰州大学优秀毕业生

近年代表文章

1. Zilong Wang1, Changyu Jiang1, Qianru He, Megumi Matsuda, Qingjian Han, Kaiyuan Wang, Sangsu Bang, Huiping Ding, Mei-Chuan Ko, Ru-Rong Ji*. Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates. Science Translational Medicine. 2020; 12 (531): eaaw6471 (1: authors contributed equally to this work)

2. Zilong Wang1*, Changyu Jiang1, Hongyu Yao, Ouyang Chen, Sreya Rahman, Yun Gu, Yul Huh, & Ru-Rong Ji*. Central opioid receptors mediate morphine-induced itch and chronic itch. Brain. 2021 Mar 3;144(2):665-681(1: authors contributed equally to this work)

3. Zilong Wang, Christopher R Donnelly, Ru-Rong Ji*. Scratching after Stroking and Poking: A Spinal Circuit Underlying Mechanical Itch. Neuron. 2019; 103: 952-954

4. Yong Chen1*, Zilong Wang1, Michele Yeo, Qiao-Juan Zhang, Ana E. López-Romero, Alan E. Medina-Arellano, Hui-Ping Ding, Xin Zhang, Qian Zeng, Sara L. Morales-Lázaro, Carlene Moore, Ying-Ai Jin, Johannes Morstein, Andrey Bortsov, Marcin Krawczyk, Frank Lammert, Anna Mae Diehl, Piotr Milkiewicz, Andreas E. Kremer, Jennifer Y. Zhang, Andrea Nackley, Tony E. Reeves, Mei-Chuan Ko, Ru-Rong Ji, Tamara Rosenbaum, Wolfgang Liedtke*. Epithelia-sensory neuron crosstalk underlies cholestatic itch induced by lysophosphatidylcholine. Gastroenterology. Accepted (1: authors contributed equally to this work)

5. Zilong Wang, Jia-Xin Pan, Jing-Jing Song, Hong-Hai Tang, Hong-Ping Yu, Xu-Hui Li, Ning Li, Ting Zhang, Run Zhang, Meng-Na Zhang, Biao Xu, Quan Fang*, Rui Wang*. Structure-based optimization of multifunctional agonists for opioid and neuropeptide FF receptors with potent non-tolerance forming analgesic activities. Journal of Medicinal Chemistry. 2016, 59 (22), 10198-10208.

6. Sharat Chandra1, Zilong Wang1, Xueshu Tao, Ouyang Chen, Xin Luo, Ru-Rong Ji, Andrey V. Bortsov. Computer-aided Discovery of a New Nav1.7 Inhibitor for Treatment of Pain and Itch. Anesthesiology. 2020; In Press. (1: authors contributed equally to this work)

7. Zilong Wang, Biao Xu, Changyu Jiang, Ting Zhang, Mengna Zhang, Ning Li, Qinqin Zhang, Kangtai Xu, Dan Chen, Jian Xiao, Quan Fang*. Spinal DN-9, a peptidic multifunctional opioid/neuropeptide FF agonist produced potent nontolerance forming analgesia with limited side effects. Journal of Pain, 2020, 21(3–4), 477−493

8. Zilong Wang1, Ning Li1, Pei Wang, Hong-hai Tang, Zheng-lan Han, Jing-jing Song, Xu-hui Li, Hong-ping Yu, Ting Zhang, Run Zhang, Biao Xu, Meng-na Zhang, Quan Fang*, Rui Wang*. Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance. Neuropharmacology. 2016; 108: 364-372 (1: authors contributed equally to this work)

9. Yang Suo, Zilong Wang, Lejla Zubcevic, Allen L Hsu, Qianru He, Mario J Borgnia, Ru-Rong Ji, Seok-Yong Lee. Structural insights into electrophile irritant sensing by the human TRPA1 channel. Neuron, 2020; 105 (5), 882-894.e5

10. Christopher R Donnelly, Changyu Jiang, Amanda S Andriessen, Kaiyuan Wang, Zilong Wang, Huiping Ding, Junli Zhao, Xin Luo, Michael S Lee, Yu L Lei, William Maixner, Mei-Chuan Ko, Ru-Rong Ji. STING controls nociception via type I interferon signaling in sensory neurons. Nature, 2021 Mar;591(7849):275-280.

研究领域

感觉神经系统疾病基础研究及药物研发。主要研究方向包括:

(1)阿片类药物镇痛及其副作用的细胞分子以及神经环路机制;

(2)镇痛或止痒药物研发;

(3)痛觉及痒觉的神经机制及新靶点的发现;

(4)免疫-神经相互作用;

(5)病理性疼痛的细胞分子机制研究及其临床治疗新药新技术研发。


教学

生理学与病理生理学(本科)


学术成果 查看更多

  1. Wang, Z., Jiang, C., Yao, H., Chen, O., Rahman, S., Gu, Y., Zhao, J., Huh, Y., and Ji, R.-R. (2021). Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition. Brain 144, 665-681. (Co-corresponding Author)
  2. Wang, Z., and Xu, Z.-Z. (2021). The Parabrachial Nucleus as a Key Regulator of Neuropathic Pain. Neuroscience Bulletin 37, 1079-1081. (Co-corresponding Author)
  3. Chen, Y., Wang, Z.-L., Yeo, M., Zhang, Q.-J., Lopez-Romero, A.E., Ding, H.-P., Zhang, X., Zeng, Q., Morales-Lazaro, S.L., Moore, C., Jin, Y.-A., Yang, H.-H., Morstein, J., Bortsov, A., Krawczyk, M., Lammert, F., Abdelmalek, M., Diehl, A.M., Milkiewicz, P., Kremer, A.E., Zhang, J.Y., Nackley, A., Reeves, T.E., Ko, M.-C., Ji, R.-R., Rosenbaum, T., and Liedtke, W. (2021). Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine. Gastroenterology 161, 301-+. (Co-First Author)
  4. Wang, Z., Jiang, C., He, Q., Matsuda, M., Han, Q., Wang, K., Bang, S., Ding, H., Ko, M.-C., and Ji, R.-R. (2020b). Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates. Science Translational Medicine 12.
  5. Wang, Z., Xu, B., Jiang, C., Zhang, T., Zhang, M., Li, N., Zhang, Q., Xu, K., Chen, D., Xiao, J., and Fang, Q. (2020a). Spinal DN-9, a Peptidic Multifunctional Opioid/Neuropeptide FF Agonist Produced Potent Nontolerance Forming Analgesia With Limited Side Effects. Journal of Pain 21, 477-493.
  6. Wang, Z., Donnelly, C.R., and Ji, R.-R. (2019). Scratching after Stroking and Poking: A Spinal Circuit Underlying Mechanical Itch. Neuron 103, 952-954.
  7. Wang, Z.-L., Pan, J.-X., Song, J.-J., Tang, H.-H., Yu, H.-P., Li, X.-H., Li, N., Zhang, T., Zhang, R., Zhang, M.-N., Xu, B., Fang, Q., and Wang, R. (2016a). Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities. Journal of Medicinal Chemistry 59, 10198-10208.
  8. Wang, Z.-l., Li, N., Wang, P., Tang, H.-h., Han, Z.-l., Song, J.-j., Li, X.-h., Yu, H.-p., Zhang, T., Zhang, R., Xu, B., Zhang, M.-n., Fang, Q., and Wang, R. (2016b). Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance. Neuropharmacology 108, 364-372.
  9. Zhang, Q., Dias, F., Fang, Q., Henry, G., Wang, Z., Suttle, A., and Chen, Y. (2022). Involvement of Sensory Neurone-TRPV4 in Acute and Chronic Itch Behaviours. Acta Derm-Venereol 102, adv00651-adv00651.
  10. Lei, V., Handfield, C., Kwock, J.T., Kirchner, S.J., Lee, M.J., Coates, M., Wang, K., Han, Q., Wang, Z., Powers, J.G., Wolfe, S., Corcoran, D.L., Fanelli, B., Dadlani, M., Ji, R.-R., Zhang, J.Y., and MacLeod, A.S. (2022). Skin Injury Activates a Rapid TRPV1-Dependent Antiviral Protein Response. The Journal of investigative dermatology.
  11. Zhao, J., Roberts, A., Wang, Z., Savage, J., and Ji, R.-R. (2021). Emerging Role of PD-1 in the Central Nervous System and Brain Diseases. Neuroscience Bulletin 37, 1188-1202.
  12. Yeo, M., Chen, Y., Jiang, C., Chen, G., Wang, K., Chandra, S., Bortsov, A., Lioudyno, M., Zeng, Q., Wang, P., Wang, Z., Busciglio, J., Ji, R.-R., and Liedtke, W. (2021). Repurposing cancer drugs identifies kenpaullone which ameliorates pathologic pain in preclinical models via normalization of inhibitory neurotransmission. Nature Communications 12.
  13. Luo, X., Chen, O., Wang, Z., Bang, S., Ji, J., Lee, S.H., Huh, Y., Furutani, K., He, Q., Tao, X., Ko, M.-C., Bortsov, A., Donnelly, C.R., Chen, Y., Nackley, A., Berta, T., and Ji, R.-R. (2021). IL-23/IL-17A/TRPV1 axis produces mechanical pain via macrophage-sensory neuron crosstalk in female mice. Neuron 109, 2691-+.
  14. Donnelly, C.R., Jiang, C., Andriessen, A.S., Wang, K., Wang, Z., Ding, H., Zhao, J., Luo, X., Lee, M.S., Lei, Y.L., Maixner, W., Ko, M.-C., and Ji, R.-R. (2021). STING controls nociception via type I interferon signalling in sensory neurons. Nature 591, 275-+.
  15. Bang, S., Donnelly, C.R., Luo, X., Toro-Moreno, M., Tao, X., Wang, Z., Chandra, S., Bortsov, A.V., Derbyshire, E.R., and Ji, R.-R. (2021). Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice. Nature Communications 12.
  16. Xu, B., Zhang, M., Shi, X., Zhang, R., Chen, D., Chen, Y., Wang, Z., Qiu, Y., Zhang, T., Xu, K., Zhang, X., Liedtke, W., Wang, R., and Fang, Q. (2020). The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via mu- and kappa-opioid receptors. British Journal of Pharmacology 177, 93-109.
  17. Suo, Y., Wang, Z., Zubcevic, L., Hsu, A.L., He, Q., Borgnia, M.J., Ji, R.-R., and Lee, S.-Y. (2020). Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel. Neuron 105, 882-+.
  18. Jiang, C., Wang, Z., Donnelly, C.R., Wang, K., Andriessen, A.S., Tao, X., Matsuda, M., Zhao, J., and Ji, R.-R. (2020). PD-1 Regulates GABAergic Neurotransmission and GABA-Mediated Analgesia and Anesthesia. Iscience 23.
  19. Chandra, S., Wang, Z., Tao, X., Chen, O., Luo, X., Ji, R.-R., and Bortsov, A.V. (2020). Computer-aided Discovery of a New Nav1.7 Inhibitor for Treatment of Pain and Itch. Anesthesiology 133, 611-627. (Co-First Author)
  20. Zhang, T., Han, Z., Shi, X., Zhao, W., Wang, Z., Zhang, R., Xu, B., Zhang, M., Zhang, Q., Xiao, J., Zhu, H., Zheng, T., and Fang, Q. (2019). Discovery of two novel branched peptidomimetics containing endomorphin-2 and RF9 pharmacophores: Synthesis and neuropharmacological evaluation. Bioorganic & Medicinal Chemistry 27, 630-643.
  21. Zhang, T., Zhang, N., Zhang, R., Zhao, W., Chen, Y., Wang, Z., Xu, B., Zhang, M., Shi, X., Zhang, Q., Guo, Y., Xiao, J., Chen, D., and Fang, Q. (2018). Preemptive intrathecal administration of endomorphins relieves inflammatory pain in male mice via inhibition of p38 MAPK signaling and regulation of inflammatory cytokines. Journal of Neuroinflammation 15.
  22. Han, Q., Liu, D., Convertino, M., Wang, Z., Jiang, C., Kim, Y.H., Luo, X., Zhang, X., Nackley, A., Dokholyan, N.V., and Ji, R.-R. (2018). miRNA-711 Binds and Activates TRPA1 Extracellularly to Evoke Acute and Chronic Pruritus. Neuron 99, 449-+.
  23. Chen, C., Xu, B., Shi, X., Zhang, M., Zhang, Q., Zhang, T., Zhao, W., Zhang, R., Wang, Z., Li, N., and Fang, Q. (2018). GpTx-1 and Ala(5), Phe(6), Leu(26), Arg(28) GpTx-1, two peptide Na(V)1.7 inhibitors: analgesic and tolerance properties at the spinal level. British Journal of Pharmacology 175, 3911-3927.
  24. Bang, S., Xie, Y.-K., Zhang, Z.-J., Wang, Z., Xu, Z.-Z., and Ji, R.-R. (2018). GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain. Journal of Clinical Investigation 128, 3568-3582.
  25. Zheng, T., Zhang, T., Zhang, R., Wang, Z.-L., Han, Z.-L., Li, N., Li, X.-H., Zhang, M.-N., Xu, B., Yang, X.-L., Fang, Q., and Wang, R. (2017). Pharmacological characterization of rat VD-hemopressin(alpha), an alpha-hemoglobin-derived peptide exhibiting cannabinoid agonist-like effects in mice. Neuropeptides 63, 83-90.
  26. Zhang, R., Xu, B., Zhang, M.-n., Zhang, T., Wang, Z.-l., Zhao, G., Zhao, G.-h., Li, N., Fang, Q., and Wang, R. (2017). Peripheral and central sites of action for anti-allodynic activity induced by the bifunctional opioid/NPFF receptors agonist BN-9 in inflammatory pain model. European journal of pharmacology 813, 122-129.
  27. Yu, H.-p., Zhang, N., Zhang, T., Wang, Z.-l., Li, N., Tang, H.-h., Zhang, R., Zhang, M.-n., Xu, B., Fang, Q., and Wang, R. (2016). Activation of NPFF2 receptor stimulates neurite outgrowth in Neuro 2A cells through activation of ERK signaling pathway. Peptides 86, 24-32.
  28. Li, X.H., Lin, M.L., Wang, Z.L., Wang, P., Tang, H.H., Lin, Y.Y., Li, N., Fang, Q., and Wang, R. (2016a). Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice. Neurogastroenterology and Motility 28, 891-899.
  29. Li, N., Han, Z.l., Wang, Z.-l., Xing, Y.-h., Sun, Y.-l., Li, X.-h., Song, J.-j., Zhang, T., Zhang, R., Zhang, M.-n., Xu, B., Fang, Q., and Wang, R. (2016b). BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice. British Journal of Pharmacology 173, 1864-1880.
  30. Chen, Y., Fang, Q., Wang, Z., Zhang, J.Y., MacLeod, A.S., Hall, R.P., and Liedtke, W.B. (2016). Transient Receptor Potential Vanilloid 4 Ion Channel Functions as a Pruriceptor in Epidermal Keratinocytes to Evoke Histaminergic Itch. Journal of Biological Chemistry 291, 10252-10262.
  31. Pan, J.-X., Wang, Z.-L., Li, N., Zhang, N., Wang, P., Tang, H.-H., Zhang, T., Yu, H.-P., Zhang, R., Zheng, T., Fang, Q., and Wang, R. (2015). Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(alpha) in naive and cannabinoid-tolerant mice. European journal of pharmacology 767, 119-125.
  32. Han, Z.-l., Wang, Z.-l., Li, X.-h., Li, N., Pan, J.-x., Zheng, T., Fang, Q., and Wang, R. (2015). Neuropeptide VF Enhances Cannabinoid Agonist WIN55,212-2-Induced Antinociception in Mice. Anesthesia and Analgesia 121, 1360-1368.
  33. Wang, Z.-l., Fang, Q., Han, Z.-l., Pan, J.-x., Li, X.-h., Li, N., Tang, H.-h., Wang, P., Zheng, T., Chang, X.-m., and Wang, R. (2014). Opposite Effects of Neuropeptide FF on Central Antinociception Induced by Endomorphin-1 and Endomorphin-2 in Mice. Plos One 9.
  34. Sun, W., Hong, L., Zhu, G., Wang, Z., Wei, X., Ni, J., and Wang, R. (2014). An Organocatalytic Michael-Michael Cascade for the Enantioselective Construction of Spirocyclopentane Bioxindoles: Control of Four Contiguous Stereocenters. Organic Letters 16, 544-547.
  35. Pan, J.-X., Wang, Z.-L., Li, N., Han, Z.-L., Li, X.-H., Tang, H.-H., Wang, P., Zheng, T., Fang, Q., and Wang, R. (2014). Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(alpha) and WIN55,212-2 at the supraspinal level in mice. Neuroscience Letters 578, 187-191.
  36. Li, X.-h., Li, N., Wang, Z.-l., Pan, J.-x., Han, Z.-l., Chang, X.-m., Tang, H.-h., Wang, P., Wang, R., and Fang, Q. (2014). The hypotensive effect of intrathecally injected (m) VD-hemopressin(alpha) in urethane-anesthetized rats. Peptides 56, 45-51.
  37. Han, Z.-l., Fang, Q., Wang, Z.-l., Li, X.-h., Li, N., Chang, X.-m., Pan, J.-x., Tang, H.-z., and Wang, R. (2014). Antinociceptive Effects of Central Administration of the Endogenous Cannabinoid Receptor Type 1 Agonist VDPVNFKLLSH-OH (m)VD-hemopressin(alpha) , an N-Terminally Extended Hemopressin Peptide. Journal of Pharmacology and Experimental Therapeutics 348, 316-323.
  38. Liu, X., Wang, Y., Xing, Y., Yu, J., Ji, H., Kai, M., Wang, Z., Wang, D., Zhang, Y., Zhao, D., and Wang, R. (2013). Design, Synthesis, and Pharmacological Characterization of Novel Endomorphin-1 Analogues as Extremely Potent mu-Opioid Agonists. Journal of Medicinal Chemistry 56, 3102-3114.
  39. Han, Z.-l., Wang, Z.-l., Tang, H.-z., Li, N., Fang, Q., Li, X.-h., Yang, X.-l., Zhang, X.-y., and Wang, R. (2013). Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice. Behavioural Brain Research 248, 51-56.
  40. Li, N., Han, Z.-l., Fang, Q., Wang, Z.-l., Tang, H.-z., Ren, H., and Wang, R. (2012). Neuropeptide FF and related peptides attenuates warm-, but not cold-water swim stress-induced analgesia in mice. Behavioural Brain Research 233, 428-433.
  41. Fang, Q., Han, Z.-L., Li, N., Wang, Z.-L., He, N., and Wang, R. (2012). Effects of neuropeptide FF system on CB1 and CB2 receptors mediated antinociception in mice. Neuropharmacology 62, 855-864.

团队成员 查看更多

加入团队

南方科技大学医学院王子龙课题组
招聘博士后Postdoctoral Researchers 2名

课题组简介
王子龙,南方科技大学医学院助理教授(Tenure-track A/P),独立课题组长,博士生导师。2017年获得兰州大学博士学位。2017-2021年在杜克大学进行博士后研究。本课题组长期致力于痛觉和痒觉的分子细胞和神经机制研究,以及镇痛或止痒药物的研发。相关成果发表在 “Science Translational Medicine”、“Brain”、“Gastroenterology”、“Neuron”等高水平杂志。
课题组的研究方向包括:(1)痛觉及痒觉的神经机制及新靶点的发现;(2)痛觉痒觉相关免疫-神经相互作用;(3)癌性、糖尿病性、化疗、神经损伤等所致病理性疼痛的细胞分子机制研究及其临床治疗新药新技术研发;(4)阿片类药物镇痛及其副作用的细胞分子以及神经环路机制。(5)离子通道相关的镇痛或止痒药物研发。
 
申请人主要研究领域和学术背景要求
 
生物学、医学相关研究背景;神经生物学、神经药理学、神经免疫学,具有痛觉或痒觉研究经验或动物行为学、膜片钳电生理、计算机辅助药物设计等研究经验者优先考虑。
 
基本要求1、已获得相关专业全日制博士学位,且获得博士学位时间一般不超过2 年。具有扎实的专业知识、研究技能和独立开展科学研究的能力,具有优秀的科学研究训练和实践记录。2、热爱科学并对神经科学研究或神经疾病药物充满兴趣,具有良好的团队合作精神。3、具有良好的英语写作能力和中英文交流能力。

岗位待遇

1、博士后聘用期两年,年薪33万元起,含广东省生活补助15万元及深圳市生活补助6万元,并按深圳市有关规定参加社会保险及住房公积金。博士后福利费参照学校教职工标准发放。2、特别优秀候选人可以申请校长卓越博士后,年薪可达41万元以上(含广东省及深圳市补助)。3、在站期间,可依托学校申请深圳市公租房,未依托学校使用深圳市公租房的博士后,可享受两年税前2800元/月的住房补贴。4、拥有优良的工作环境和境内外合作交流机会,博士后在站期间享受两年共计2.5万学术交流经费资助。


申请材料

详细的个人简历,含学习、工作和科研的经历,主要科研成果(论文、专利、论著等),以及其他可以证明工作能力的材料。至少提供2 名推荐人的姓名及有效联系方式。
请申请者讲上述材料整合为单个PDF 文件发送。

应聘方式

应聘者请将以上应聘材料整合为单个PDF,发至邮箱wangzl6@sustech.edu.cn,收到邮件后我们会尽快回复,并邀请面试。本招聘公告长期有效,期待加盟!
 
查看更多

联系我们

联系地址

广东省深圳市南山区学苑大道1088号慧园5栋309

办公电话

0755-8801 0526

电子邮箱

wangzl6@sustech.edu.cn

Copyright © 2018 All Rights Reserved.